Clinical Trials
1
Active:0
Completed:0
Trial Phases
1 Phases
Phase 2:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 2
1 (100.0%)BXOS110 Injection in the Treatment of Acute Ischaemic Stroke
Phase 2
Recruiting
- Conditions
- Acute Ischemic Stroke
- Interventions
- Drug: PlaceboDrug: low-dose BXOS110Drug: high-dose BXOS110
- First Posted Date
- 2024-03-21
- Last Posted Date
- 2024-03-21
- Lead Sponsor
- Biocells (Beijing) Biotech Co.,Ltd
- Target Recruit Count
- 300
- Registration Number
- NCT06322394
- Locations
- 🇨🇳
Yuebei People's Hospital, Shaoguan, Guangdong, China
🇨🇳Harrison International Peace Hospital, Hengshui, Hebei, China
🇨🇳The First Hospital of Hebei Medical University, Shijiazhuang, Hebei, China
News
No news found